“…To challenge the argument made by Dr Kuindersma and Dr Spronk [ 4 ], do we simply ignore these sizeable subgroups or use them to generate hypotheses and conduct prospective studies to better understand the science underlying both COVID-19 pathophysiology and individual responses to any intervention? We would disagree with them on the prognostic utility of the baseline CRP value.…”